Changes in Thyroid Replacement Therapy after Bariatric Surgery: Differences between Laparoscopic Roux-en-Y Gastric Bypass and Laparoscopic Sleeve Gastrectomy
Sign Up to like & getrecommendations! Published in 2019 at "Obesity Surgery"
DOI: 10.1007/s11695-019-03890-9
Abstract: IntroductionLevothyroxine (LT4) requirements can presumably be modified differently after laparoscopic Roux-en-Y gastric bypass (LRYGB) and laparoscopic sleeve gastrectomy (LSG). The present study compared changes in LT4 dose in hypothyroid subjects undergoing LRYGB or LSG 2 years… read more here.
Keywords: surgery; gastric bypass; mcg day; laparoscopic roux ... See more keywords
Dose-finding study of a 90-day contraceptive vaginal ring releasing estradiol and segesterone acetate.
Sign Up to like & getrecommendations! Published in 2020 at "Contraception"
DOI: 10.1016/j.contraception.2020.05.004
Abstract: OBJECTIVE To evaluate serum estradiol (E2) concentrations during use of 90-day contraceptive vaginal rings releasing E2 75, 100, or 200 mcg/day and segesterone acetate (SA) 200 mcg/day to identify a dose that avoids hypoestrogenism. Study… read more here.
Keywords: segesterone acetate; 200 mcg; mcg day; contraceptive vaginal ... See more keywords
A First-in-Human Phase I Study of Subcutaneous Outpatient Recombinant Human IL15 (rhIL15) in Adults with Advanced Solid Tumors
Sign Up to like & getrecommendations! Published in 2017 at "Clinical Cancer Research"
DOI: 10.1158/1078-0432.ccr-17-2451
Abstract: Purpose: Preclinical data established IL15 as a homeostatic factor and powerful stimulator of NK and CD8+ T-cell function, the basis for clinical testing. Experimental Design: A first-in-human outpatient phase I dose escalation trial of subcutaneous… read more here.
Keywords: mcg day; outpatient; first human; human phase ... See more keywords